EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Potential theranostics of breast cancer with copper-64/67 sarcophagine-trastuzumab

Stacey E Rudd iD, Jessica Van Zuylekom iD, Carleen Cullinane, Benjamin J Blyth iD, Paul S Donnelly iD

Chemical Science · 2025 · 16 (9) · 3998-4005

DOI: 10.1039/d4sc06969b ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Science, 2025. Verfasst von Stacey E Rudd und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne Melbourne Victoria 3010 Australia stacey.rudd@un…. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Australian Research Council, National Health and Medical Research Council, Australian Cancer Research Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An antibody for Human Epidermal Growth Factor Receptor 2 (HER2) radiolabelled with copper-67 has high therapeutic efficacy in a mouse model of HER2 positive tumours.

Autor:innen und Institutionen

  • School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne Melbourne Victoria 3010 Australia stacey.rudd@unimelb.edu.au pauld@unimelb.edu.au.
  • Models of Cancer Translational Research Centre, Research Division, Peter MacCallum Cancer Centre 305 Grattan St Melbourne Victoria 3000 Australia.
  • Sir Peter MacCallum Department of Oncology, The University of Melbourne Parkville Victoria 3010 Australia.

ORCID-Profile: Stacey E Rudd, Jessica Van Zuylekom, Benjamin J Blyth, Paul S Donnelly

Förderung

  • Australian Research Council
  • National Health and Medical Research Council
  • Australian Cancer Research Foundation

Zitieren

APA

Rudd, S. E., Van Zuylekom, J., Cullinane, C., Blyth, B. J., & Donnelly, P. S. (2025). Potential theranostics of breast cancer with copper-64/67 sarcophagine-trastuzumab. Chemical Science, 16(9), 3998-4005. https://doi.org/10.1039/d4sc06969b

Vancouver

Rudd SE, Van Zuylekom J, Cullinane C, Blyth BJ, Donnelly PS. Potential theranostics of breast cancer with copper-64/67 sarcophagine-trastuzumab. Chemical Science. 2025;16(9):3998-4005. doi:10.1039/d4sc06969b

BibTeX
@article{Rudd2025,
  author = {Rudd, Stacey E and Van Zuylekom, Jessica and Cullinane, Carleen and Blyth, Benjamin J and Donnelly, Paul S},
  title = {Potential theranostics of breast cancer with copper-64/67 sarcophagine-trastuzumab},
  journal = {Chemical Science},
  year = {2025},
  volume = {16},
  number = {9},
  pages = {3998--4005},
  doi = {10.1039/d4sc06969b}
}
Kostenlos starten →